Free Republic
Browse · Search
General/Chat
Topics · Post Article

To: ransomnote
Figure it out.

Someone pointed this out over at greatawakening.win

FDA Approves First Oral Blood Thinning Medication for Children
For Immediate Release:
June 21, 2021

"Today, the U.S. Food and Drug Administration approved Pradaxa (dabigatran etexilate) oral pellets to treat children 3 months to less than 12 years old with venous thromboembolism (a condition where blood clots form in the veins) directly after they have been treated with a blood thinner given by injection for at least five days. The FDA also approved Pradaxa oral pellets to prevent recurrent clots among patients 3 months to less than 12 years old who completed treatment for their first venous thromboembolism."

1,334 posted on 08/26/2021 2:29:08 AM PDT by Ymani Cricket ( "Pressure Makes Diamonds" ~General Patton)
[ Post Reply | Private Reply | To 1331 | View Replies ]


To: Ymani Cricket
...to prevent recurrent clots among patients 3 months to less than 12 years old who completed treatment for their first venous thromboembolism."

They know what the vaccines are causing, and have already prepared "treatments" for the damage.

What punishment would be too "cruel or inhumane" for these monsters?

1,335 posted on 08/26/2021 2:43:35 AM PDT by meadsjn (, )
[ Post Reply | Private Reply | To 1334 | View Replies ]

To: Ymani Cricket; bitt; grey_whiskers; HarleyLady27; sweetiepiezer; LucyT; norsky; ransomnote

Ymani Cricket wrote:

“Figure it out.
Someone pointed this out over at greatawakening.win

FDA Approves First Oral Blood Thinning Medication for Children
For Immediate Release:
June 21, 2021

“Today, the U.S. Food and Drug Administration approved Pradaxa (dabigatran etexilate) oral pellets to treat children 3 months to less than 12 years old with venous thromboembolism (a condition where blood clots form in the veins) directly after they have been treated with a blood thinner given by injection for at least five days. The FDA also approved Pradaxa oral pellets to prevent recurrent clots among patients 3 months to less than 12 years old who completed treatment for their first venous thromboembolism.”

Ymani, all

When did that medication get developed and start it’s clinical trials?


1,349 posted on 08/26/2021 4:21:38 AM PDT by WildHighlander57 ((WildHighlander57 returning after lurking since 2000) )
[ Post Reply | Private Reply | To 1334 | View Replies ]

Free Republic
Browse · Search
General/Chat
Topics · Post Article


FreeRepublic, LLC, PO BOX 9771, FRESNO, CA 93794
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson